Company Filing History:
3 out of 3 
2 out of 196 
1 out of 19 Years Active: 2019-2024
Title: Kim Lynette Askew: Innovator in Cardiovascular Treatments
Introduction
Kim Lynette Askew is a prominent inventor based in Lincoln, MA (US). She has made significant contributions to the field of cardiovascular health through her innovative research and patented inventions. With a total of five patents to her name, Askew is recognized for her dedication to improving patient outcomes in cardiovascular disease.
Latest Patents
Among her latest patents, Askew has developed methods for improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1). This invention provides methods for enhancing cardiovascular function in human patients, such as reducing hypertension. Additionally, she has created methods for treating tissue calcification, addressing NPP1 deficiency and associated diseases like idiopathic infantile arterial calcification and vascular calcification in chronic kidney disease. These groundbreaking methods involve administering soluble NPP1 to increase serum pyrophosphate levels temporarily.
Career Highlights
Throughout her career, Askew has worked with notable companies, including Inozyme Pharma, Inc. and Alexion Pharmaceuticals, Inc. Her work in these organizations has allowed her to further her research and contribute to advancements in medical treatments.
Collaborations
Some of her notable coworkers include Anthony Quinn and Nelson Hsia. Their collaboration has likely played a role in the development of her innovative patents and research.
Conclusion
Kim Lynette Askew is a trailblazer in the field of cardiovascular treatments, with her patents reflecting her commitment to advancing medical science. Her work continues to impact the lives of patients suffering from cardiovascular diseases.